Log In
person
Recordati Industria Chimica E Farmaceutica SPA, Mila
summarize
4 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (EUR) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (EUR) | Percentage |
| Rare Diseases |
Branded Pharmaceuticals
These companies research, develop, and manufacture patented drugs.
|
0.71B | 34.32% |
| Specialty & Primary Care |
Branded Pharmaceuticals
These companies research, develop, and manufacture patented drugs.
|
1B | 48.12% |
| Specialty & Primary Care |
Over-the-Counter Pharmaceuticals
These companies research, develop, and manufacture over-the-counter (OTC) drugs, or those that do not require a doctor's prescription.
|
0.31B | 14.96% |
| Specialty & Primary Care |
Pharmaceuticals and Active Ingredients for Pharmaceuticals
These companies develop and manufacture both finished pharmaceuticals directly to distributors along with Active Pharmaceutical Ingredients (APIs) to other pharmaceutical manufacturers.
|
0.05B | 2.59% |
| keyboard_arrow_down |
Rare Diseases
Branded Pharmaceuticals
|
0.71B | 34.32% |
| keyboard_arrow_right |
These companies research, develop, and manufacture patented drugs.
|
||
| keyboard_arrow_down |
Specialty & Primary Care
Branded Pharmaceuticals
|
1B | 48.12% |
| keyboard_arrow_right |
These companies research, develop, and manufacture patented drugs.
|
||
| keyboard_arrow_down |
Specialty & Primary Care
Over-the-Counter Pharmaceuticals
|
0.31B | 14.96% |
| keyboard_arrow_right |
These companies research, develop, and manufacture over-the-counter (OTC) drugs, or those that do not require a doctor's prescription.
|
||
| keyboard_arrow_down |
Specialty & Primary Care
Pharmaceuticals and Active Ingredients for Pharmaceuticals
|
0.05B | 2.59% |
| keyboard_arrow_right |
These companies develop and manufacture both finished pharmaceuticals directly to distributors along with Active Pharmaceutical Ingredients (APIs) to other pharmaceutical manufacturers.
|
||